Summary A 60-year-old woman with severe aortic stenosis (AS) and congenital bicuspid aortic valve was admitted to our hospital due to cardiogenic pulmonary edema. Noninvasive adaptive servo-ventilation (ASV) improved her symptoms and respiratory status. It was associated with favorable hemodynamic effects including an increase in cardiac output and a decrease in pulmonary vascular resistance without alternating systemic blood pressure. An improvement in oxygenation and the favorable hemodynamic effects might lead to the stabilization of clinical status. Noninvasive ventilation with ASV can avert tracheal intubation by improving oxygenation and is expected to be convenient and useful in the treatment of acute pulmonary edema.
Introduction
Acute cardiogenic pulmonary edema is a common medical emergency. It is a leading cause of hospitalization and its in-hospital mortality is as high as 10-20% [1, 2] . Patients who do not respond to initial therapy often require tracheal intubation and ventilation, which may lead to respiratory complications. Recently, noninvasive ventilation such as continuous positive air way pressure (CPAP) or noninvasive intermittent positive pressure ventilation (NIPPV) has been shown to avert tracheal intubation by improving oxygenation with favorable hemodynamic effects [3, 4] . Adaptive servoventilation (ASV) has been widely accepted as one of the new therapies for patients with heart failure, especially, with Cheyne-Stokes respiration [5] [6] [7] [8] [9] . ASV has been postulated to have several physiological advantages compared to CPAP and NIPPV. ASV has low levels of background expiratory positive airway pressure (EPAP) with variable levels of inspiratory positive airway pressure (IPAP) support which depends on the respiratory status of each patient by automatic mechanical control [5] . Moreover, ASV is designed to reduce hyperventilation by regulating minute ventilation within 90% of the average values during previous few minutes. Based on these advantages of ASV, it is expected that the noninvasive ventilation by using ASV can be effective in the treatment of acute cardiogenic pulmonary edema. This is a report showing successful ASV therapy for a patient with acute pulmonary edema associated with severe aortic stenosis.
Case report
A 60-year-old woman diagnosed as having aortic stenosis (AS) with congenital bicuspid aortic valve was admitted to our hospital due to worsening nocturnal dyspnea in July 2009. On admission, her heart rate was 100 beats per minute and blood pressure was 104/68 mmHg. She had irregular pulse, loud diamond-shaped systolic ejection murmur at the second right sternal border which radiated to subclavicular region, and coarse crackles at both lungs. Chest X-ray showed prominent pulmonary congestion and the enlargement of the heart (cardiothoracic ratio 64%) with pleural effusion ( Fig. 1(a) ). A 12-lead electrocardiogram (ECG) revealed sinus rhythm with sporadic premature ventricular beats and left ventricular (LV) hypertrophy. BNP was elevated to 2743 pg/ml. She was treated with diuretics and low-dose phosphodiesterase (PDE) inhibitor parentally with oxygenation of 3 l/min through the nose. In spite of our initial treatment, she had worsening nocturnal dyspnea and orthopnea.
Her respiratory rate was increased up to 34 times/min and oxygen saturation decreased to 95% despite the administration of 10 l/min oxygen with mask.
Moreover, arterial blood gas data revealed hypoxia (pO 2 60.0 mmHg) and hypercapnea (pCO 2 52.7 mmHg) in spite of hyperventilation due to massive pleural effusion (Table 1 ; Fig. 1(a) ). In order to stabilize her respiratory status, ASV was started with oxygenation of 10 l/min by using the Autoset CS R (Teijin Co, Tokyo, Japan) and full face masks (Teijin Fig. 1(b) ). Moreover, ASV was associated with favorable hemodynamic effects with oxygenation (Table 2) . These data showed an increase in cardiac output and stroke volume, and also the decrease in pulmonary vascular resistance and systemic vascular resistance without major changes in blood pressure and heart rate during ASV. After stabilization, we could perform echocardiography and catheterization in a supine position. Echocardiography revealed that aortic valve area (AVA) was 0.57 cm 2 (Doppler method), peak LV-aorta pressure gradient (LV-Ao PG) was 56 mmHg, mean LV-Ao PG was 34.3 mmHg, and LV ejection fraction was 20% (Fig. 2) . Coronary angiography revealed no significant organic stenosis. Therefore, we diagnosed her as having severe aortic stenosis without ischemic heart disease, and then, performed surgical operation (aortic valve replacement; The St. Jude Medical standard ® bileaflet valve 23 mm; St. Jude Medical, St Paul, MN, USA) as an emergency. The surgical operation was performed without any major complication, and the postoperative course was favorable. 
Discussion
This report demonstrated that noninvasive ventilation using ASV is useful for the treatment of a patient with acute cardiogenic pulmonary edema due to severe aortic stenosis. Tracheal intubation and mechanical ventilation using sedatives are frequently required for the stabilization of respiratory status in patients with acute pulmonary edema. However, these procedures may increase the risk for cardiogenic shock and respiratory complication. If once the patient with severe aortic stenosis should develop cardiogenic shock, it is sometimes very hard to improve the hemodynamic status even with the use of intra-aortic balloon pumping (IABP) and percutaneous cardiopulmonary support (PCPS).
Gray et al. reported that noninvasive ventilation such as CPAP or NIPPV induced a more rapid improvement in respiratory distress and metabolic disturbance than standard oxygen therapy in patients with acute cardiogenic pulmonary edema [10] . Moreover, noninvasive methods of ventilation could avert tracheal intubation by improving oxygenation, reducing the work of breathing, and increasing cardiac output due to preload and afterload reduction and improvement of the oxygenation [11] [12] [13] . Increases in intrathoracic pressure could decrease LV afterload and augment LV ejection. The important hemodynamic effects of ASV are the preload reduction due to the decrease in excessive venous return via an increase in intrathoracic pressure by EPAP (5 cm) and the afterload reduction through the decrease in myocardial transmural pressure gradient. These beneficial effects of both preload and afterload reduction and the maintenance of those in good balance by ASV might lead to its favorable hemodynamics. Especially, in patients with hypervolemic heart failure, this prominent afterload reducing effect can result in improved LV ejection, increased cardiac output, and reduced myocardial oxygen demand, all of which can be seen by the use of IABP [14] . Furthermore, ASV can improve oxygen delivery to the tissue by increasing cardiac output as well as oxygenation [15] . As a result, ASV can lead to the improvement of clinical status of the patient with cardiogenic pulmonary edema.
The present report suggests that ASV is similarly effective as noninvasive methods of ventilation such as NIPPV or CPAP in patients with cardiogenic pulmonary edema. Moreover, it should be emphasized that ASV has several important advantages compared to other conventional methods of noninvasive ventilation. NIPPV performs forced ventilation with constant pressure regardless of the respiration of the patient. Moreover, the delicate and complicated adjustments of positive airway pressure setting or titration are needed for each patient. Therefore, conventional NIPPV might not only disturb the therapeutic adherence or acceptability for the patient with heart failure, but also increase the activity of sympathetic nerve, which may induce fatal cardiac arrhythmias. On the other hand, ASV can support the breathing of the pressure wave form similar to spontaneous respiration and maintain 90% of the average minute ventila- tion during most recent 3 min by regulating IPAP and timing of the backup support automatically based on the default mechanical setting, which may minimize the activation of sympathetic activity. In fact, as for our patient who received ASV therapy, the respiratory status and the hemodynamics were drastically improved and clearly stabilized thereafter in our patient. Moreover, fatal cardiac arrhythmia never occurred during ASV therapy. ASV was quite convenient and useful for the patient with cardiogenic pulmonary edema. However, we could not perform polysomnography before and during ASV for this patient because of her poor condition. We thus need to acknowledge this point as a limitation that we could not precisely evaluate the effects of ASV on the apnea-hypopnea index (AHI) and the status of Cheyne-Stokes respiration associated with heart failure. Moreover, we could not determine the superiority of ASV directly compared to other noninvasive methods of ventilation or its mechanisms.
Conclusion
ASV is one of the most useful and safe therapies in noninvasive ventilation for acute cardiogenic pulmonary edema.
